CLEPTOMANIA: ENTRE EL TRASTORNO DE CONTROL DE LOS IMPULSOS Y LAS CONDUCTAS ADICTIVAS

(especial para SIIC © Derechos reservados)
En la actualidad la cleptomanía está clasificada como un subtipo impulsivo dentro de los trastornos del espectro obsesivo compulsivo. Los inhibidores selectivos de la recaptación de serotonina son los fármacos de primera línea.
Autor:
Pn Dannon
Columnista Experto de SIIC

Institución:
Tel Aviv University


Artículos publicados por Pn Dannon
Coautor
G Berman* 
Tel Aviv University, Tel-Aviv, Israel*
Recepción del artículo
12 de Agosto, 2012
Aprobación
21 de Septiembre, 2012
Primera edición
9 de Noviembre, 2012
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
Generalmente, se cree que la cleptomanía es un cuadro clínico infrecuente, y caracterizado por el fracaso reiterado para intentar resistir el impulso de robar varios objetos no necesarios para el uso personal o por su valor monetario. En la actualidad, hay muchos investigadores que proponen subdividir a los pacientes con cleptomanía según la comorbilidad psiquiátrica, la respuesta a los psicofármacos y la posible etiología. Estos grupos son: 1) trastornos del control de los impulsos; 2) espectro obsesivo compulsivo; 3) espectro afectivo; 4) una conducta adictiva. Los inhibidores de la recaptación selectiva de serotonina (IRSS) son el grupo de sustancias más utilizadas para el tratamiento de esta enfermedad. La naltrexona (NTX), un antagonista opioide empleado en el tratamiento de la dependencia alcohólica, también resultaría eficaz en el tratamiento de la cleptomanía. De todas maneras, al programar la estrategia terapéutica hay que considerar las condiciones comórbidas del paciente, especialmente los trastornos del ánimo y el abuso de fármacos. También, es importante evaluar los problemas maritales, laborales y legales en estos individuos.

Palabras clave
cleptomanía, inhibidores selectivos de la recaptación de serotonina, trastorno del espectro obsesivo compulsivo, conducta adictiva, naltrexona


Artículo completo

(castellano)
Extensión:  +/-13.02 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Kleptomania is generally believed to be a rare clinical condition, characterized by a recurrent failure to resist the impulse to steal objects not needed for personal use or for their monetary value. Currently several researchers propose to subdivide kleptomania patients into several groups based on psychiatric comorbidity, responsiveness to psychopharmacology and possible aetiology. They are: 1) the "impulse control" disorders, 2) the "obsessive-compulsive" spectrum, 3) the "affective" spectrum, and 4) a "behavioural addiction". SSRI's seem to be the most common group of drugs in the treatment of kleptomania. Naltrexone, an opioid antagonist for the treatment of alcohol dependence, has also proved to be effective. However, treatment planning must take into account considerations raised by comorbid conditions (mainly mood disorders and substance use disorders). In addition marital, occupational and legal problems may require additional assistance by professionals in the related fields.

Key words
kleptomania, selective serotonin reuptake inhibitor, obsessive compulsive disorder spectrum, behavioral addiction, naltrexone


Full text
(english)
para suscriptores/ assinantes

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Salud Mental
Relacionadas: Atención Primaria, Salud Pública



Comprar este artículo
Extensión: 13.02 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Pinhas Dannon, Aviv University Sackler School of Medicine Israel, 70350, Beer Yaacov Mental Health Center & Tel 1 Beer Yaacov, Beer Yaacov, Israel
Bibliografía del artículo

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association, 2000.
2. Goldman MJ. Kleptomania making sense of nonsensical. Am J Psychiatry 148:986-996, 1991.
3. Goldman MJ. Kleptomania: an overview. Psychiatric Annals 22:68-71, 1992.
4. Grant JE and Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry 43(5):378-384, 2002a.
5. Glover JH. A case of kleptomania treated by covert sensitization. Br J Clin Psychol 24:213-214, 1985.
6. Gudjonsson GH. The significance of depression in the mechanism of 'compulsive' shoplifting. Med Sci Law 27 (3):171-176, 1987.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
8. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, World Health Organization, 1992.
9. Aizer A, Lowengrub K, Dannon PN, Kleptomania after haed trauma: two case reports and combination treatment strategies. Clin Neuropharmacology 27 (5):211-218, 2004.
10. Kozian R. Kleptomania in frontal lobe lesion. Psychiatr Prax 28 (2):98-99, 2001.
11. Mendez MF. Pathological stealing in dementia. J Am Geriatr Soc 36 (9):825-6, 1988.
12. Segal M. Shoplifting [letter]. Br Med J 1: 960, 1976.
13. McElroy SL, Keck PL, Pope HG, et al. Kleptomania: Clinical characteristics and associated psychopathology. Psycholog Med 21:93-108, 1991a.
14. Grant JE, Potenza MN, Krishnan-Sarin S, Cavallo DA, Desai RA. Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law 39 (1):44-52, 2011a.
15. Odlaug BL, Grant JE. Impulse-control disorders in a college sample: results from the self-administered Minnesota Impulse Disorders Interview (MIDI). Prim Care Companion J Clin Psychiatry 12 (2), 2010.
16. McElroy SL, Keck PE Jr, Phillips KA. Kleptomania, compulsive buying, and binge-eating disorder. J Clin Psychiatry 56 (Suppl 4):14-26, 1995.
17. Bradford J, Balmaceda R. Shoplifting: is there a specific psychiatric syndrome? Can J Psychiatry 28:248-254, 1983.
18. Dannon PN, Lowengrub K, Iancu I, Kotler M. Kleptomania: Comorbid psychiatric diagnosis in patients and their families. Psychopathology 37:76-80, 2004.
19. Hudson JL, Pope HG. An affective spectrum disorder. Am J Psychiatry 147:552-556, 1990.
20. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry 56 (suppl 4):3-6, 1995.
21. Dannon PN, Lowengrub K, Sasson M, Tuson B, Shalgi L, Saphir Y, Kotler M. Comorbid psychiatric diagnoses in kleptomania and pathological gambling: a preliminary comparison study. Eur Psychiatry 19 (5):299-302, 2004b.
22. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry 43 (5):378-384, 2002.
23. Aboujaoude E, Gamel N, Koran LM. Overview of Kleptomania and Phenomenological Description of 40 Patients. Prim Care Companion J Clin Psychiatry 6 (6):244-247, 2004.
24. Grant JE. Co- occurrence of personality disorders in persons with kleptomania: a preliminary investigation. J Am Acad Psychiatry Law 32 (4):395-398, 2004.
25. Iancu I, Lowengrub K, Dembinsky Y, Kotler M, Dannon PN. Pathological gambling: An update on the neuropathophysiology and pharmacotherapy. CNS drugs 22 (2): 123-138, 2008.
26. Müller A, Rein K, Kollei I, Jacobi A, Rotter A, Schütz P, Hillemacher T, de Zwaan M. Impulse control disorders in psychiatric inpatients. Psych res 188, 434-438, 2011.
27. Lepkifker E, Dannon PN, Ziv R, et al. The treatment of kleptomania with serotonine reuptake inhibitors. Clin Neuropharmacol 22:40-43, 1999.
28. Baylé FJ , Caci B, Mullet B, Richa S, Olié JP. Psychppathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry 160 (8):1509-1513, 2003.

29. McElroy SL, Hudson JL, Pope HG, et al. The DSM-III-R impulse control disorders not elsewhere classified: Clinical Characteristics and relationships to other psychiatric disorders. Am J Psychiatry 149:318-327, 1992.
30. McElroy SL, Pope HG, Hudson JL, et al Kleptomania: a report of 20 cases. Am J Psychiatry 148:652-657, 1991b.
31. McElroy SL, Phillips KA, Keck PE jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry 55 Suppl:33-51; discussion 52-53, 1994.
32. Fontenelle LF, Medlowicz MV, Versiani m. Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatry clin neurosci 59:30-37, 2005.
33. Du Toit PL, Van Kradenburg J, Neihaus D, Stein DJ. Comparison of obsessive-compulsive patients with and without comorbid putative obssesive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 42 (4):291-300, 2001.
34. Lochner C, Hemmings SM, Kinnear CJ, Neihaus DJ, Nel DG, Corfield VA, Moolman-Smook JC, Seedat S, Stein DJ. Cluster analysis of obssesive-compulsive spectrum disorders in patients with obssesive-compulsive disorders: clinical and genetic correlates. Compr Psychiatry 46 (1): 14-19, 2005.
35. Lochner C, and Stein DJ. Obsessive-compulsive spectrum disorders in obsessive-compulsive disorders and other anxiety disorders 43: 389-396, 2010.
36. McElroy SL, Pope HG, Keck PE, Hudson JL, Phillips KA, Srtakowski SM. Are impulse-control disorders related to bipolar disorder? Copmr Psychiatry 37: 229-240, 1996.
37. Sarasalo E, Bergman B, Toth J. Personality traits and psychiatric and somatic morbidity among kleptomaniacs. Acta Psychiatr Scand 94 (5):358-364, 1996.
38. Grant JE. Understanding and treating kleptomania: new models and new treatments. Isr J psychiatry relat sci 43 (2): 81-87, 2006.
39. Grant JE, Odlaug BL, Kim SW. Kleptomania: clinical characteristics and relationship to substance use disorders. Am J Drug Alcohol Abuse 36 (5):291-295, 2010.
40. Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 65 (7):600-606, 2009.
41. Grant JE. Family history and psychiatric comorbidity in persons with kleptomania. Compr psychiatry 44: 437-441, 2003.
42. Presta S, Marazziti D, Dell’Osso L, Pfanner C, Pallanti S and Cassano GB. Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry 43: 7–12, 2002.
43. Grant JE, Kim SW. Open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 63(4):349-355, 2002.
44. Grant JE, Kim SW, Grosz RL. Perceived stress in kleptomania. Psychiatr Q 74 (3):251-258, 2003.
45. Schwartz JH. Psychoanalytic psychotherapy for a woman with diagnosis of kleptomania. Hosp Community Psychiatry 43:109-110, 1992.
46. Chong SA, Low BL. Treatment of kleptomania with fluvoxamine. Acta Psychitr Scand 93; 314-315, 1996.
47. Grant JE. Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol 28(1):11-14, 2005.
48. Talih FR. Kleptomania and potential exacerbating factors: a review and case report. Innov clin neurosci 8 (10): 35-39, 2011.
49. Durst R, Katz G, Jabotinsky-Rubin K, Knobler HY. Kleptomania: phenomenological, clinical, and legal aspects [Article in Hebrew]. Harefua 133 (10): 441-444, 1997.
50. Rossi R. Diagnostic of sexual perversions. J Endocrinol Invest 26 (3 Suppl):109-111, 2003.
51. Grant JE, Kim SW, A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry 13 (4):229-231, 2001.
52. Fishbain DA. Kleptomania as risk-taking behavior in response to depression. Am J Psychother 41 (4):598-603, 1987.
53. Turnbull JM. Sexual relationships of patients with kleptomania. South Med J 80 (8):995-998, 1987.
54. Warmann WA. The use of aversion therapy to treat kleptomania. Psychopathologie Africaine 16 (1):77-82, 1980.
55. Gauthier J, Pellerin D. Management of compulsive shoplifting through covert sensitization. J Behav Ther Exp Psychiatry 13 (1):73-75, 1982.
56. Marzagao LR. Systematic desensitization treatment of kleptomania. J Behav Therapy & Experimental Psychiatry 3 (4):327-328, 1972.
57. Hollander E. Treatment of obsessive compulsive spectrum disorder with SSRIs. Brit J Psychiatry 35 (suppl):7-12, 1998.
58. Burstein A. Fluoxetine-lithium treatment for kleptomania. J Clin Psychiatry 53 (1):28-29, 1992.
59. Dannon PN, Iancu I, Grunhaus L. Naltrexone treatment in kleptomanic patients. Human Psychopharm 14:583-585, 1999.
60. Kraus Kraus JE. Treatment of kleptomania with paroxetine. J Clin Psychiatry 60(11):793, 1999.
61. Koran LM, Aboujaoude EN, Gamel NN. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J clin psychiatry 68(3):422-427, 2007.
62. Kindler S, Dannon PN, Iancu I, et al. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Clin Neuropharmacol 20(2):126-129, 1997.
63. Fishbain DA. Kleptomanic behavior response to perphenazine-amitriptyline HCL combination. Can J Psychiatry 33:241-242, 1988.
64. Kmetz GF, McElroy SL, Collins DJ. Response of kleptomania and mixed mania to valproate. Am J Psychiatry 154 (4):580-581, 1997.
65. Priest RG, Gimbrett R, Roberts M, Steinert J. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. Acta Psychiatr Scand (Suppl) 386:40-43, 1995.
66. Volpicelli JR, Clay KL, Watson NT, et al. Naltrexone in the treatment of alcoholizm. J Clin Psychiatry 56 (Suppl 7):39-44, 1995.
67. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 59:159-164, 1998.
68. Anton RF. Pharmacological approaches to the management of alcoholism. J Clin Psychiatry 62( suppl 20):11-17, 2001.
69. Dannon PN. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol. 26(1):1-4, 2003.
70. Grant JE. Kleptomania treated with tolcapone, a catechol-O-methyl-transferase (COMT) inhibitor. Prog Neuropsychopharmacol Biol Psychiatry 35: 295-296, 2011.
71. Pallanti S, Grassi G, Sarrechia ED, Cantisani A, Pellegrini M. Obsessice-compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry. 2:70, 2011. Epub 2011 Dec 21.


 
 
 
 
 
 
Clasificado en
Artículos originales>
Expertos del Mundo

Especialidad principal:
Salud Mental


Relacionadas:
Atención Primaria
Salud Pública
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618